05/01/2026
The 2026 UK Forum returns to London Jun. 11, bringing a dynamic agenda of discussions such as "Discovery disrupted: The next frontier of molecular innovation", chaired by Dr. Anne-Marie Martin (GSK), who will be joined by:
Dr. Karin Conde-Knape, PhD
Chief Scientific Officer, Valo Health
Dr. Elizabeth Schwarzbach, PhD
Chief Business Officer, BigHat Biosciences
Dr. Rupert Vessey, BM, B*h, DPhil, FRCP
Chief Scientist and Executive Partner, Flagship Pioneering
Prof. Paul Workman, OBE, PhD, FRS
Harrap Professor of Pharmacology & Former President and Chief Executive, The Institute of Cancer Research (ICR); Co-director, CRUK Children's Brain Tumour Centre of Excellence, ICR & Cambridge University; Director, Chemical Probes Portal